Stroke onset to needle delay: Where these golden hours are lost? An Egyptian center experience

BACKGROUND: The use of intravenous recombinant tissue plasminogen activator (IV r-tPA) in early acute ischemic stroke (AIS) management faces a lot of difficulties in developing countries due to lessened guideline development with consecutive pre- and intra-hospital delay. OBJECTIVES: The objective w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahnasy, Wafik Said, Ragab, Osama Abd Allah, Elhassanien, Mahmoud Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330381/
https://www.ncbi.nlm.nih.gov/pubmed/30671551
http://dx.doi.org/10.1016/j.ensci.2019.01.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330381/
https://www.ncbi.nlm.nih.gov/pubmed/30671551
http://dx.doi.org/10.1016/j.ensci.2019.01.003

Ejemplares similares